The rally saw the stock advance past its 20-day Simple Moving Average of 1765.3 as well as its second and third resistance levels during early morning trading. By 09:23 AM IST, shares were trading at Rs 1795.6 with a price-to-earnings ratio of 34.93 and earnings per share standing at 50.41. The early turnaround comes against a backdrop of longer-term weakness, as shares had fallen by 11.5% over the preceding three-month period. Meanwhile, trading activity saw 1,107,854 shares change hands, approaching the weekly average volume of 1,414,082 shares.
Key points
The pharmaceutical firm is attempting a technical recovery after dropping by 5.58% over t…: The pharmaceutical firm is attempting a technical recovery after dropping by 5.58% over the past month.
The morning upward momentum broke through several established resistance benchmarks after…: The morning upward momentum broke through several established resistance benchmarks after the previous session closed at Rs 1757.5.
Sun Pharma recorded a market capitalization of 422,522.89 alongside earnings per share of…: Sun Pharma recorded a market capitalization of 422,522.89 alongside earnings per share of 50.41 as shares traded at Rs 1795.6.
Sources checked by our analysis pipeline: 1
30 Oct 2026 | 09:23:46 AM IST
Sun Pharma share price live updates
Welcome to the Sun Pharma Stock Liveblog, your real-time source for the latest updates and comprehensive analysis on a prominent stock. Dive into the current details of Sun Pharma, including: Last traded price 1795.6, Market capitalization: 422522.89, Volume: 166135, Price-to-earnings ratio 34.93, Earnings per share 50.41. Our liveblog offers a complete overview of Sun Pharma through a blend of fundamental and technical indicators. Stay informed about breaking news that can shape Sun Pharma's performance in the market. Our market analysis and expert opinions empower you to make informed investment decisions. Join us as we unravel the potential of Sun Pharma in the ever-changing market landscape. The data points are updated as on 09:23:45 AM IST, 30 Oct 2026
Show more Show less
1 New Update
09:23:38 AM IST, 30 Oct 2026
Sun Pharma Share Price Live Updates: Sun Pharma's Stock Surges Past Resistance Level
Sun Pharma has experienced a positive price breakout and is trading above its third resistance level (R3), with the price currently at Rs…
The benchmark index faced significant selling pressure throughout the trading day, culminating in a notable retreat by the closing bell. Market participants witnessed widespread weakness that pulled the island's primary equity gauge down sharply during the session. The downward momentum reflects a challenging environment for local shares across the entire exchange.
Mainland bourses dropped to a one-year low after overnight Wall Street declines spread worries about the profitability and high infrastructure costs of artificial intelligence. The resulting retreat dragged Chinese hardware and semiconductor equities sharply lower, despite resilient trading across Hong Kong and consumer-focused industries. Investors increasingly rotated into defensive domestic segments to limit exposure to the broader regional downturn.
Investor sentiment turned sharply negative as mounting profitability pressures overshadowed the renewable energy firm's operational momentum. The market selloff was triggered by deteriorating profit margins and lower full-year operational guidance. These margin constraints have prompted several brokerage houses to swiftly downgrade their price targets despite robust delivery volumes.